
Opinion|Videos|November 17, 2023
Myelodysplastic Syndrome (MDS) Overview
Ryan Haumschild, PharmD, MS, MBA, CPEL, opens the discussion by defining the MDS disease state.
Advertisement
Episodes in this series

Now Playing
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Prescription Access Crisis: 40% of GLP-1 RA Rx Are Unfilled
2
Value-Based Care Offers Solutions to Patient Access Challenges: Brian Mulherin, MD
3
New WHO Reports Sounds Alarm on Antimicrobial Resistance
4
Why Education and Collaboration Are Key to Bispecific Therapy Administration: Amir Fathi, MD
5